Alternative splicing variant of RHBDD2 is associated with cell stress response and breast cancer progression

  • Authors:
    • Romina Canzoneri
    • Martín Enrique Rabassa
    • Agustina Gurruchaga
    • Valeria Ferretti
    • Sabina Palma
    • Marina Isla‑Larrain
    • María Virginia Croce
    • Ezequiel Lacunza
    • Martín Carlos Abba
  • View Affiliations

  • Published online on: June 14, 2018     https://doi.org/10.3892/or.2018.6489
  • Pages: 909-915
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

RHBDD2 is an intramembrane pseudoprotease member of the Rhomboid superfamily. Our previous studies in breast and colorectal cancer indicate an association between RHBDD2 overexpression and advanced tumor stages. Two alternative transcriptional variants have been described for RHBDD2, which would be encoding for different RHBDD2 protein isoforms. The expression of these RHBDD2 variants/isoforms and its association with breast cancer was the focus of this study. First, expression of RHBDD2 splicing variants was evaluated in normal and breast tumor samples. RHBDD2 variant 2 overexpression was detected in tumors in respect to normal breast tissues at the mRNA and protein levels (P<0.05). Moreover, RHBDD2 variant 2 expression was associated with poor prognostic factors such as basal‑like intrinsic subtype (P<0.05), high proliferation (P<0.01) and long‑term risk‑of‑recurrence (P<0.01) scores. Second, the expression of both variants was evaluated under nutritional‑deprived conditions in breast cancer cell lines. Results demonstrated that RHBDD2 splicing was switched from mRNA variant 1 to variant 2 in association with a significant increment of protein isoform B in response to glucose starvation treatment. Therefore, we propose that the switch from the RHBDD2 variant 1, expressed in normal epithelial cells, to variant 2 occurs as an adaptive phenotype to bypass the stressful tumor microenvironment and promote tumor progression. Finally, the RHBDD2 subcellular localization was corroborated at the Golgi apparatus and their associated v‑SNARE transport vesicles, suggesting a putative new role for RHBDD2 in the protein trafficking of human breast cancer cells.
View Figures
View References

Related Articles

Journal Cover

August-2018
Volume 40 Issue 2

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Canzoneri R, Rabassa ME, Gurruchaga A, Ferretti V, Palma S, Isla‑Larrain M, Croce MV, Lacunza E and Abba MC: Alternative splicing variant of RHBDD2 is associated with cell stress response and breast cancer progression. Oncol Rep 40: 909-915, 2018.
APA
Canzoneri, R., Rabassa, M.E., Gurruchaga, A., Ferretti, V., Palma, S., Isla‑Larrain, M. ... Abba, M.C. (2018). Alternative splicing variant of RHBDD2 is associated with cell stress response and breast cancer progression. Oncology Reports, 40, 909-915. https://doi.org/10.3892/or.2018.6489
MLA
Canzoneri, R., Rabassa, M. E., Gurruchaga, A., Ferretti, V., Palma, S., Isla‑Larrain, M., Croce, M. V., Lacunza, E., Abba, M. C."Alternative splicing variant of RHBDD2 is associated with cell stress response and breast cancer progression". Oncology Reports 40.2 (2018): 909-915.
Chicago
Canzoneri, R., Rabassa, M. E., Gurruchaga, A., Ferretti, V., Palma, S., Isla‑Larrain, M., Croce, M. V., Lacunza, E., Abba, M. C."Alternative splicing variant of RHBDD2 is associated with cell stress response and breast cancer progression". Oncology Reports 40, no. 2 (2018): 909-915. https://doi.org/10.3892/or.2018.6489